Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Inducing apoptosis is a key cancer therapy strategy, but cancer cells employ survival mechanisms and immune evasion tactics.
• Apoptotic cells and tumor microenvironment (TME) components can paradoxically promote cancer progression and immune escape.
• Apoptosis critically influences the efficacy and longevity of anti-tumor T-cell responses.

Purpose of the Study:

• To review challenges and strategies for targeting apoptosis in cancer therapy.
• To explore combined approaches that enhance anti-tumor immunity by modulating apoptosis.
• To identify potential drug targets for synergistic cancer treatments.

Main Methods:

• Literature review of apoptosis induction, cancer cell survival, and immune evasion mechanisms.
• Analysis of the role of the tumor microenvironment (TME) in apoptosis and immune responses.
• Exploration of combined therapeutic strategies targeting apoptosis and T-cell function.

Main Results:

• Cancer cells resist apoptosis through complex biological mechanisms.
• Modulating the TME and promoting immunogenic cell death are crucial for therapeutic success.
• Balancing tumor cell apoptosis induction with T-cell preservation is essential for durable anti-cancer immunity.

Conclusions:

• Effective cancer therapy requires precise targeting of apoptosis, balancing tumor cell death with T-cell persistence and function.
• Combined strategies involving apoptosis modulation, immunogenic cell death, and T-cell support offer potential to overcome resistance.
• Identifying druggable targets is key to developing novel combination therapies for enhanced anti-tumor immune responses.